Verekitug

Drug identity checked against registry records

Also recorded as UPB-101

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPDNCT06981078UPBPhase 2Active not recruiting2027-10Estimated
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)NCT06966479UPBPhase 2Active not recruiting2027-09Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.